A detailed history of Madison Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Madison Wealth Management holds 2,745 shares of ABBV stock, worth $481,418. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,745
Previous 2,810 2.31%
Holding current value
$481,418
Previous $378,000 8.2%
% of portfolio
0.09%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$133.59 - $154.65 $8,683 - $10,052
-65 Reduced 2.31%
2,745 $409,000
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $7,950 - $9,894
60 Added 2.18%
2,810 $378,000
Q1 2023

May 08, 2023

SELL
$144.61 - $166.54 $3,615 - $4,163
-25 Reduced 0.9%
2,750 $438,000
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $671 - $769
5 Added 0.18%
2,775 $372,000
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $29,543 - $37,380
275 Added 11.02%
2,770 $375,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $6,490 - $7,367
-61 Reduced 2.39%
2,495 $269,000
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $11,783 - $13,127
112 Added 4.58%
2,556 $288,000
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $11,150 - $12,275
109 Added 4.67%
2,444 $264,000
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $187,944 - $253,744
2,335 New
2,335 $250,000
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $192,008 - $225,355
-2,235 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $163,981 - $219,432
2,235 New
2,235 $219,000
Q1 2020

May 08, 2020

SELL
$64.5 - $97.79 $148,866 - $225,699
-2,308 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $166,476 - $208,297
2,308 New
2,308 $204,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Madison Wealth Management Portfolio

Follow Madison Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Madison Wealth Management with notifications on news.